Show simple item record

dc.contributor.authorBramness, Jørgen Gustav
dc.contributor.authorvon Soest, Tilmann
dc.date.accessioned2019-10-08T11:14:13Z
dc.date.available2019-10-08T11:14:13Z
dc.date.issued2019-02-26
dc.description.abstract<p><i>Background - </i>A small number of studies have shown that the use of cannabis increases the risk of bronchial asthma. There is, however, a paucity of longitudinal studies which are able to control for known risk factors of bronchial asthma. <p><i>Methods - </i>Survey data from a population-based longitudinal study encompassing 2602 young adults followed for 13 years were coupled with individual prescription data on asthma medication (β<sub>2</sub>-adrenergic receptor agonists and glucocorticoids for inhalation) from the Norwegian national prescription database, which covers the entire Norwegian population. Current cannabis use, gender, age, years of education, body mass index (BMI; kg/m<sup>2</sup>) and current smoking were measured. <p><i>Results - </i>Prescription of asthma medication was associated with female gender, self-reported earlier asthma and allergies, daily tobacco smoking and current cannabis use. In a model adjusting for gender, age, years of education, BMI, earlier self-reported asthma and allergies and current tobacco smoking the odds ratio for a current cannabis user to fill prescriptions for asthma medication was 1.71 (95% CI: 1.06–2.77; <i>p</i> = 0.028). <p><i>Conclusions - </i>This suggests that cannabis is a risk factor for bronchial asthma or use of asthma medication even when known risk factors are taken into consideration. Intake of cannabis through smoking should be avoided in persons at risk.en_US
dc.description.sponsorshipResearch Council of Norwayen_US
dc.descriptionSource at <a href=https://doi.org/10.1186/s12890-019-0814-x>https://doi.org/10.1186/s12890-019-0814-x</a>.en_US
dc.identifier.citationBramness, J.G. & von Soest T. (2019). A longitudinal study of cannabis use increasing the use of asthma medication in young Norwegian adults. <i>BMC Pulmonary Medicine, 19</i>, 52. https://doi.org/10.1186/s12890-019-0814-xen_US
dc.identifier.doi10.1186/s12890-019-0814-x
dc.identifier.issn1471-2466
dc.identifier.urihttps://hdl.handle.net/10037/16356
dc.language.isoengen_US
dc.publisherBMCen_US
dc.relation.journalBMC Pulmonary Medicine
dc.rights.accessRightsopenAccessen_US
dc.subjectVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Lung diseases: 777en_US
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Lungesykdommer: 777en_US
dc.subjectAdolescenten_US
dc.subjectCannabisen_US
dc.subjectAsthma medicationen_US
dc.subjectLongitudinalen_US
dc.subjectSmokingen_US
dc.titleA longitudinal study of cannabis use increasing the use of asthma medication in young Norwegian adultsen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


File(s) in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record